vs
MGP INGREDIENTS INC（MGPI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
MGP INGREDIENTS INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍（$138.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -23.5%），MGP INGREDIENTS INC自由现金流更多（$24.3M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -9.9%）
MGP配料公司是总部位于美国的优质蒸馏酒、特种小麦和玉米基淀粉及蛋白质配料供应商，服务食品饮料制造、餐饮及工业客户领域，为北美及部分全球市场客户提供定制化配料解决方案。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MGPI vs PBYI — 直观对比
营收规模更大
MGPI
是对方的1.8倍
$75.5M
营收增速更快
PBYI
高出51.2%
-23.5%
自由现金流更多
MGPI
多$9.9M
$14.4M
两年增速更快
PBYI
近两年复合增速
-9.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $138.3M | $75.5M |
| 净利润 | $-134.6M | — |
| 毛利率 | 34.9% | 69.3% |
| 营业利润率 | -97.7% | 22.7% |
| 净利率 | -97.3% | — |
| 营收同比 | -23.5% | 27.7% |
| 净利润同比 | -220.8% | — |
| 每股收益（稀释后） | $-6.23 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MGPIPBYI
| Q4 25 | $138.3M | $75.5M | ||
| Q3 25 | $130.9M | $54.5M | ||
| Q2 25 | $145.5M | $52.4M | ||
| Q1 25 | $121.7M | $46.0M | ||
| Q4 24 | $180.8M | $59.1M | ||
| Q3 24 | $161.5M | $80.5M | ||
| Q2 24 | $190.8M | $47.1M | ||
| Q1 24 | $170.6M | $43.8M |
净利润MGPIPBYI
| Q4 25 | $-134.6M | — | ||
| Q3 25 | $15.4M | $8.8M | ||
| Q2 25 | $14.4M | $5.9M | ||
| Q1 25 | $-3.0M | $3.0M | ||
| Q4 24 | $-42.0M | — | ||
| Q3 24 | $23.9M | $20.3M | ||
| Q2 24 | $32.1M | $-4.5M | ||
| Q1 24 | $20.6M | $-4.8M |
毛利率MGPIPBYI
| Q4 25 | 34.9% | 69.3% | ||
| Q3 25 | 37.8% | 77.7% | ||
| Q2 25 | 40.1% | 76.5% | ||
| Q1 25 | 35.6% | 77.1% | ||
| Q4 24 | 41.2% | 76.4% | ||
| Q3 24 | 40.8% | 63.9% | ||
| Q2 24 | 43.6% | 77.4% | ||
| Q1 24 | 36.8% | 75.5% |
营业利润率MGPIPBYI
| Q4 25 | -97.7% | 22.7% | ||
| Q3 25 | 16.1% | 17.6% | ||
| Q2 25 | 14.0% | 12.7% | ||
| Q1 25 | -0.6% | 8.7% | ||
| Q4 24 | -16.8% | 22.6% | ||
| Q3 24 | 20.2% | 27.4% | ||
| Q2 24 | 22.7% | -4.6% | ||
| Q1 24 | 17.0% | -5.3% |
净利率MGPIPBYI
| Q4 25 | -97.3% | — | ||
| Q3 25 | 11.8% | 16.2% | ||
| Q2 25 | 9.9% | 11.2% | ||
| Q1 25 | -2.5% | 6.5% | ||
| Q4 24 | -23.2% | — | ||
| Q3 24 | 14.8% | 25.2% | ||
| Q2 24 | 16.8% | -9.6% | ||
| Q1 24 | 12.1% | -11.0% |
每股收益（稀释后）MGPIPBYI
| Q4 25 | $-6.23 | $0.26 | ||
| Q3 25 | $0.71 | $0.17 | ||
| Q2 25 | $0.67 | $0.12 | ||
| Q1 25 | $-0.14 | $0.06 | ||
| Q4 24 | $-1.86 | $0.40 | ||
| Q3 24 | $1.07 | $0.41 | ||
| Q2 24 | $1.43 | $-0.09 | ||
| Q1 24 | $0.92 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.5M | $97.5M |
| 总债务越低越好 | $245.9M | $22.7M |
| 股东权益账面价值 | $718.4M | $130.3M |
| 总资产 | $1.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.34× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MGPIPBYI
| Q4 25 | $18.5M | $97.5M | ||
| Q3 25 | $13.4M | $94.4M | ||
| Q2 25 | $17.3M | $96.0M | ||
| Q1 25 | $20.1M | $93.2M | ||
| Q4 24 | $25.3M | $101.0M | ||
| Q3 24 | $20.8M | $96.7M | ||
| Q2 24 | $21.0M | $96.8M | ||
| Q1 24 | $19.5M | $107.2M |
总债务MGPIPBYI
| Q4 25 | $245.9M | $22.7M | ||
| Q3 25 | $262.3M | $34.0M | ||
| Q2 25 | $290.7M | $45.3M | ||
| Q1 25 | $290.7M | $56.7M | ||
| Q4 24 | $317.1M | $68.0M | ||
| Q3 24 | $283.6M | $79.3M | ||
| Q2 24 | $303.0M | $90.7M | ||
| Q1 24 | $294.4M | $102.0M |
股东权益MGPIPBYI
| Q4 25 | $718.4M | $130.3M | ||
| Q3 25 | $855.2M | $115.3M | ||
| Q2 25 | $841.8M | $104.7M | ||
| Q1 25 | $828.3M | $97.1M | ||
| Q4 24 | $834.2M | $92.1M | ||
| Q3 24 | $914.5M | $71.1M | ||
| Q2 24 | $894.5M | $48.5M | ||
| Q1 24 | $867.0M | $51.0M |
总资产MGPIPBYI
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.4B | $202.9M | ||
| Q2 25 | $1.4B | $194.9M | ||
| Q1 25 | $1.4B | $196.2M | ||
| Q4 24 | $1.4B | $213.3M | ||
| Q3 24 | $1.4B | $220.7M | ||
| Q2 24 | $1.4B | $205.0M | ||
| Q1 24 | $1.4B | $214.1M |
负债/权益比MGPIPBYI
| Q4 25 | 0.34× | 0.17× | ||
| Q3 25 | 0.31× | 0.30× | ||
| Q2 25 | 0.35× | 0.43× | ||
| Q1 25 | 0.35× | 0.58× | ||
| Q4 24 | 0.38× | 0.74× | ||
| Q3 24 | 0.31× | 1.12× | ||
| Q2 24 | 0.34× | 1.87× | ||
| Q1 24 | 0.34× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $29.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $24.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 17.5% | 19.1% |
| 资本支出强度资本支出/营收 | 3.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $76.0M | $41.7M |
8季度趋势，按日历期对齐
经营现金流MGPIPBYI
| Q4 25 | $29.1M | $14.4M | ||
| Q3 25 | $36.1M | $9.7M | ||
| Q2 25 | $11.7M | $14.1M | ||
| Q1 25 | $44.7M | $3.6M | ||
| Q4 24 | $28.8M | $15.6M | ||
| Q3 24 | $43.9M | $11.0M | ||
| Q2 24 | $5.0M | $1.0M | ||
| Q1 24 | $24.6M | $11.2M |
自由现金流MGPIPBYI
| Q4 25 | $24.3M | $14.4M | ||
| Q3 25 | $27.6M | $9.7M | ||
| Q2 25 | $-557.0K | $14.1M | ||
| Q1 25 | $24.8M | $3.6M | ||
| Q4 24 | $10.4M | $15.6M | ||
| Q3 24 | $24.5M | $11.0M | ||
| Q2 24 | $-1.4M | $1.0M | ||
| Q1 24 | $-2.4M | — |
自由现金流率MGPIPBYI
| Q4 25 | 17.5% | 19.1% | ||
| Q3 25 | 21.1% | 17.7% | ||
| Q2 25 | -0.4% | 26.8% | ||
| Q1 25 | 20.4% | 7.7% | ||
| Q4 24 | 5.8% | 26.4% | ||
| Q3 24 | 15.2% | 13.7% | ||
| Q2 24 | -0.7% | 2.1% | ||
| Q1 24 | -1.4% | — |
资本支出强度MGPIPBYI
| Q4 25 | 3.5% | 0.0% | ||
| Q3 25 | 6.5% | 0.0% | ||
| Q2 25 | 8.4% | 0.0% | ||
| Q1 25 | 16.4% | 0.1% | ||
| Q4 24 | 10.1% | 0.0% | ||
| Q3 24 | 12.0% | 0.0% | ||
| Q2 24 | 3.3% | 0.0% | ||
| Q1 24 | 15.8% | 0.0% |
现金转化率MGPIPBYI
| Q4 25 | — | — | ||
| Q3 25 | 2.34× | 1.10× | ||
| Q2 25 | 0.81× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.84× | 0.54× | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 1.19× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MGPI
| Branded Spirits | $63.4M | 46% |
| Ingredient Solutions | $31.3M | 23% |
| Specialty Wheat Starches | $16.8M | 12% |
| Mid Spirits | $16.1M | 12% |
| Other Branded Spirits | $8.0M | 6% |
| Commodity Wheat Starch | $2.3M | 2% |
PBYI
暂无分部数据
